Figure 5.

Verteporfin (VP) treatment inhibits cell viability and cell cycle by repressing YAP in NKTCL cells. (A) Cell viability was assessed by MTT assay in NKTCL cells treated with VP or transfected with YAP encoding plasmid. (B) Cell cycle was measured by flow cytometry analysis in NKTCL cells treated with VP or transfected with YAP encoding plasmid. (C) Cell number in G1, S and G2 stages for different groups. All the results were shown as mean ± SD (n = 3), which were three separate experiments performed in triplicate. *P < 0.05. **P < 0.01